AcelRx Pharmaceuticals has named Mark G. Edwards to its board of directors. Edwards will also serve as the chairman of the audit committee.
Edwards founded Deloitte Recap (formerly, Recombinant Capital), a pharmaceutical and biotechnology consulting company, in 1988, and served as its managing director until the end of 2010. Recap has provided analysis, advice and negotiation support concerning the structure and valuation of biopharmaceutical alliances to several hundred companies over the past two decades.
"Mark brings a wealth of both financial and pharmaceutical industry partnering transaction experience to AcelRx," noted Richard King, AcelRx president and chief executive officer.